424 studies found for:    immunoglobuling OR Inmunoglobulina [TREATMENT] AND HIV [CONDITION]
Show Display Options
Rank Status Study
1 Recruiting Dynamic Changes of Sera Immunoglobulin G4 and Interleukin-10 in the Patients of Pancreatic Cancer After Chemotherapy
Conditions: Pancreatic Neoplasms;   Inflammation
Intervention: Other: gemcitabine-based chemotherapy
2 Active, not recruiting IVIG Treatment for Asthmatic Patients With IgG Subclass Deficiency
Condition: Asthma
Intervention: Drug: Immune Globulin
3 Completed PNEUMOCELL - Conjugated Pneumococcal Vaccination in Patients With Immunoglobulin G-deficiency
Condition: IgG Deficiency
Intervention: Biological: Prevenar13
4 Completed A Phase I Study of Recombinant Human CD4 Immunoglobulin G (rCD4-lgG) in Patients With HIV-Associated Immune Thrombocytopenic Purpura
Conditions: Immune Thrombocytopenic Purpura ( ITP );   HIV Infections
Intervention: Drug: CD4-IgG
5 Completed A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in Infants and Children With Documented HIV-1 Infection
Condition: HIV Infections
Intervention: Drug: CD4-IgG
6 Completed A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in HIV-1 Seropositive Women During the Last Trimester of Pregnancy and Their Newborns
Conditions: HIV Infections;   Pregnancy
Intervention: Drug: CD4-IgG
7 Completed A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4-Immunoglobulin G (rCD4-IgG) Administered by Intravenous Bolus Injection in Combination With Oral Zidovudine in Patients With AIDS and AIDS-Related Complex
Condition: HIV Infections
Interventions: Drug: CD4-IgG;   Drug: Zidovudine
8 Terminated GCIV as an Adjuvant Therapy for Community-Acquired Severe Sepsis or Septic Shock
Conditions: Severe Sepsis;   Septic Shock
Intervention: Drug: Immunoglobulin G
9 Completed Safety Study of Subcutaneous Ig NextGen 16% in Patients With Primary Immunodeficiency
Condition: Primary Immune Deficiency
Intervention: Drug: Immunoglobulin G (Ig NextGen 16%)
10 Terminated
Has Results
IVIG Versus Placebo for the Treatment of Patients With Severe C-Diff
Condition: Clostridium Difficile-associated Diarrhea (CDAD)
Interventions: Drug: intravenous immunoglobulin G (IVIG);   Drug: Placebo
11 Active, not recruiting Immunoglobulin for Necrotizing Soft Tissue Infections: a Randomised Controlled Trial
Conditions: Necrotizing Soft Tissue Infection;   Necrotizing Fasciitis;   Gas Gangrene;   Fournier Gangrene
Interventions: Drug: IVIG (Privigen);   Drug: Saline 0.9%
12 Completed IVIG - West Nile Encephalitis: Safety and Efficacy
Condition: West Nile Virus
Interventions: Drug: Omr-lgG-am;   Drug: Polygam® S/D;   Drug: Placebo
13 Recruiting Phase III Efficacy, Safety, and Tolerability Study of HYQVIA/HyQvia and GAMMAGARD LIQUID/KIOVIG in CIDP
Condition: Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Interventions: Biological: HYQVIA;   Biological: 0.25% albumin placebo solution with rHuPH20;   Biological: IGIV
14 Not yet recruiting Treatment of IgG4-Related Disease With Revlimid and Rituximab
Condition: Immunoglobulin G Subclass 4 Related Disease
Interventions: Drug: Rituximab;   Drug: Lenalidomide
15 Completed
Has Results
Phase II Study, Evaluation of Safety and Efficacy of Immunoglobulin G Degrading Enzyme of Streptococcus Pyogenes (IdeS) in Chronic Kidney Disease
Condition: Chronic Kidney Disease
Intervention: Biological: IdeS
16 Recruiting Treatment of Obstructive Jaundice in Autoimmune Pancreatitis and/or Immunoglobulin G4-related Sclerosing Cholangitis by Corticosteroids
Conditions: Autoimmune Pancreatitis;   IgG4-related Sclerosing Cholangitis;   Obstructive Jaundice
Interventions: Drug: corticosteroids;   Procedure: biliary stent
17 Recruiting Effect of Privigen Against Graft Loss
Condition: Kidney Transplantation
Intervention: Drug: Privigen (Human normal immunoglobulin G (IgG > 98 % purity))
18 Completed
Has Results
Efficacy and Safety of Vivaglobin® in Previously Untreated Patients With Primary Immunodeficiency
Conditions: Common Variable Immunodeficiency;   Agammaglobulinemia
Intervention: Drug: Vivaglobin
19 Recruiting A Pilot Trial To Assess The Feasibility And Efficacy Of SCIG In Patients With MG Exacerbation (SCIG-MG)
Condition: Myasthenia Gravis
Intervention: Drug: Human normal immunoglobulin G (IgG)
20 Recruiting Study of Immune Deficiency Patients Treated With Subcutaneous Immunoglobulin (IgPro20, Hizentra®) on Weekly and Biweekly Schedules
Conditions: Primary Immune Deficiency;   Secondary Immune Deficiency
Intervention: Biological: Subcutaneous Immune Globulin (Human) (Hizentra)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years